Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective

Journal Title: Istanbul Medical Journal - Year 2019, Vol 20, Issue 2

Abstract

Introduction: We aimed to investigate the levels of receptor activator of nuclear factor kappa-b ligand (RANKL) and osteoprotegerin (OPG) in order to evaluate the negative effects of type 2 diabetes mellitus on bone health and their relationship to the severity of disease based on the treatment. We also evaluated the relationship between hemoglobin A1c (HbA1c), parathyroid hormone (PTH) and bone specific alkaline phosphatase (BAP) levels and RANKL and OPG levels. Methods: The study group consisted of 19 volunteers (15 females and 4 males) and 65 patients with type 2 diabetes mellitus (49 females and 16 males). In order to evaluate the relationship between the treatment and the disease severity, the patient group was divided into two subgroups: patients treated with oral anti-diabetics (OAD) (sulfonylurea and metformin) or insulin. The levels of glucose, calcium, phosphorus, HbA1c, BAP, PTH, RANKL and OPG were compared. Results: The RANKL and OPG levels of patients treated with insulin were significantly higher than the control group (p=0.008, p=0.033, respectively). However, there was no significant difference in the OAD group for both parameters (p=0.1, p=0.46, respectively). There was no significant difference between the groups in terms of PTH and BAP levels (p=0.97, p=0.66, respectively). Conclusion: We believe that RANKL and OPG levels are higher in patients with poor glycemic control and that they may be indicators of disease severity.

Authors and Affiliations

Alper Gümüş, Muhammed Emin Düz, Cihan Coşkun, Mustafa Velet, Macit Koldaş

Keywords

Related Articles

Effect of Postpartum Depression and Anxiety on Infant Development at 12 Months: A One-year Follow-up Study

Introduction: To evaluate the effect of maternal postpartum depression (PPD) and anxiety disorder (AD) during the postnatal first year on infant development at 12 months. Methods: This prospective study was conducted at...

Electrocardiographic Alterations in Patients with Common Variable Immune Deficiency

Introduction: Common variable immunodeficiency (CVID) is the most heterogeneous group among the antibody deficiency syndromes, but its effects on the cardiovascular system have not yet been clearly identified. Here, we a...

Predictors of Complex Aortic Plaques in Patients Undergoing Transoesophageal Echocardiography

Introduction: Atrial fibrillation (AF) is one of the most important causes of ischaemic stroke according to the TOAST classification. The CHA2DS2-VASc score is a widely used scoring system for estimating systemic thrombo...

Prediction of Prognostic Factors in the Survival of Non-small-cell Lung Cancer Patients with Multiple Brain Metastases

Introduction: We aimed to investigate the factors affecting survival in non-small-cell lung cancer (NSCLC) patients with multiple brain metastases. Methods: One hundred thirty patients who were diagnosed with NSCLC at t...

Diplopia Due to Orbital Myositis: Diagnosis with Magnetic Resonance Imaging

Orbital myositis is a non-specific inflammatory disease primarily affecting the extraocular muscles. It is most commonly seen in young adults and women and is often unilateral. Periorbital pain, swelling and redness of t...

Download PDF file
  • EP ID EP549085
  • DOI 10.4274/imj.galenos.2018.04657
  • Views 194
  • Downloads 0

How To Cite

Alper Gümüş, Muhammed Emin Düz, Cihan Coşkun, Mustafa Velet, Macit Koldaş (2019). Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective. Istanbul Medical Journal, 20(2), -. https://europub.co.uk./articles/-A-549085